European surveillance of emerging pathogens associated with canine infectious respiratory disease
Autor: | Mitchell, Judy A, Cardwell, Jacqueline M, Leach, Heather, Walker, Caray A, Le Poder, Sophie, Decaro, Nicola, Rusvai, Miklos, Egberink, Herman, Rottier, Peter, Fernandez, Mireia, Fragkiadaki, Eirini, Shields, Shelly, Brownlie, Joe, dI&I I&I-1, LS Klinisch Onderzoek Wagenaar, LS Virologie, dI&I I&I-4 |
---|---|
Přispěvatelé: | Royal Veterinary College - University of London, Virologie UMR1161 (VIRO), École nationale vétérinaire d'Alfort (ENVA)-Institut National de la Recherche Agronomique (INRA)-Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Department of Veterinary Medicine, University of Cambridge [UK] (CAM), Department of Pathology, University of Veterinary Medicine, Department of Infectious Diseases and Immunology, Utrecht University [Utrecht], Universitat Autònoma de Barcelona (UAB), Faculty of Animal Science and Aquaculture, Agricultural University of Athens, Zoetis, Zoetis Animal Health, Petplan Charitable Trust, dI&I I&I-1, LS Klinisch Onderzoek Wagenaar, LS Virologie, dI&I I&I-4 |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Disease occurrence Canine pneumovirus (CnPnV) Communicable Diseases Emerging 0403 veterinary science Mycoplasma cynos Mycoplasma Coronavirus Canine Prevalence Dog Diseases Respiratory Tract Infections biology Respiratory disease 04 agricultural and veterinary sciences General Medicine Canine influenza (CIV) 3. Good health Europe Influenza A virus Epidemiological Monitoring Antibody Coronavirus Infections Kennel cough 040301 veterinary sciences Microbiology Article Virus 03 medical and health sciences Dogs Orthomyxoviridae Infections medicine Animals Pneumovirus Infections Mycoplasma Infections Canine respiratory coronavirus (CRCoV) Canine pneumovirus [SDV.BA.MVSA]Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health Pneumovirus General Veterinary Canine distemper business.industry medicine.disease Virology 030104 developmental biology Immunology biology.protein Canine infectious respiratory disease (CIRD) business |
Zdroj: | Veterinary Microbiology Veterinary Microbiology, Elsevier, 2017, 212, pp.31-38. ⟨10.1016/j.vetmic.2017.10.019⟩ Veterinary Microbiology, 212, 31. Elsevier VETERINARY MICROBIOLOGY |
ISSN: | 0378-1135 |
DOI: | 10.1016/j.vetmic.2017.10.019 |
Popis: | Highlights • The largest study of its kind in the field to date, including high-risk kennelled dogs, and for the first time, pet dogs and dogs from other cohorts. • A clearly identifiable link between disease and the emerging pathogens: canine respiratory coronavirus and canine pneumovirus. • Provides, substantial evidence of CIRD and the circulation of the novel pathogens studied in pet dogs, and dogs from other cohorts. • Demonstrates the role and limitations of current vaccine strategies in managing CIRD outbreaks, and the need for including emerging pathogens. Canine infectious respiratory disease (CIRD) is a major cause of morbidity in dogs worldwide, and is associated with a number of new and emerging pathogens. In a large multi-centre European study the prevalences of four key emerging CIRD pathogens; canine respiratory coronavirus (CRCoV), canine pneumovirus (CnPnV), influenza A, and Mycoplasma cynos (M. cynos); were estimated, and risk factors for exposure, infection and clinical disease were investigated. CIRD affected 66% (381/572) of the dogs studied, including both pet and kennelled dogs. Disease occurrence and severity were significantly reduced in dogs vaccinated against classic CIRD agents, canine distemper virus (CDV), canine adenovirus 2 (CAV-2) and canine parainfluenza virus (CPIV), but substantial proportions (65.7%; 201/306) of vaccinated dogs remained affected. CRCoV and CnPnV were highly prevalent across the different dog populations, with overall seropositivity and detection rates of 47% and 7.7% for CRCoV, and 41.7% and 23.4% for CnPnV, respectively, and their presence was associated with increased occurrence and severity of clinical disease. Antibodies to CRCoV had a protective effect against CRCoV infection and more severe clinical signs of CIRD but antibodies to CnPnV did not. Involvement of M. cynos and influenza A in CIRD was less apparent. Despite 45% of dogs being seropositive for M. cynos, only 0.9% were PCR positive for M. cynos. Only 2.7% of dogs were seropositive for Influenza A, and none were positive by PCR. |
Databáze: | OpenAIRE |
Externí odkaz: |